r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

SA

Sanofi

Insider · 10% owner · LTGO

Sanofi files insider transactions with the SEC as a 10% owner of Latigo Biotherapeutics (LTGO). We hold 1 disclosed purchase or sale filed since 11 February 2008, 1 of them in the last 90 days.

  • Files forLTGO
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure12 August 2026

Positions held

14 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 10 August 2026 — 10 August 202610% owner · Latigo Biotherapeutics (LTGO)4 Form 4 lines · source: SEC Form 4
  • Filed 6 August 2026 — 6 August 202610% owner · Attovia Therapeutics (ATTO)3 Form 4 lines · source: SEC Form 4
  • Filed 14 September 2021 — 14 September 202110% owner · Translate Bio (TBIO)2 Form 4 lines · source: SEC Form 4
  • Filed 2 August 2021 — 2 August 202110% owner · Icosavax (ICVX)4 Form 4 lines · source: SEC Form 4
  • Filed 28 July 2020 — 28 July 202010% owner · Inozyme Pharma (INZY)3 Form 4 lines · source: SEC Form 4
  • Filed 27 January 2014 — 9 June 202010% owner · Regeneron Pharmaceuticals (REGN)550 Form 4 lines · source: SEC Form 4
  • Filed 22 July 2019 — 22 July 201910% owner · Fulcrum Therapeutics (FULC)3 Form 4 lines · source: SEC Form 4
  • Filed 3 November 2015 — 13 February 201910% owner · MyoKardia (MYOK)8 Form 4 lines · source: SEC Form 4
  • Filed 25 March 2014 — 31 May 201710% owner · Alnylam Pharmaceuticals (ALNY)7 Form 4 lines · source: SEC Form 4
  • Filed 10 November 2015 — 16 November 2015Other role · Voyager Therapeutics (VYGR)3 Form 4 lines · source: SEC Form 4
  • Filed 4 February 2014 — 4 February 201410% owner · Regulus Therapeutics (RGLS)1 Form 4 line · source: SEC Form 4
  • Filed 31 January 2013 — 5 February 2013Other role · Kalobios Pharmaceuticals (KBIO)2 Form 4 lines · source: SEC Form 4
  • Filed 9 February 2010 — 11 February 201010% owner · Chattem (CHTT)4 Form 4 lines · source: SEC Form 4
  • Filed 31 December 2007 — 31 December 2007Other role · Idm Pharma (IDMI)1 Form 4 line · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.